Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease

Lea Lemaitre,Nia Adeniji,Akanksha Suresh,Reshma Reguram,Josephine Zhang,Jangho Park,Amit Reddy,Alexandro E Trevino,Aaron T Mayer,Anja Deutzmann,Aida S Hansen,Ling Tong,Vinodhini Arjunan,Neeraja Kambham,Brendan C Visser,Monica M Dua,C Andrew Bonham,Nishita Kothary,H Blaize D'Angio,Ryan Preska,Yanay Rosen,James Zou,Vivek Charu,Dean W Felsher,Renumathy Dhanasekaran

DOI: https://doi.org/10.1038/s43018-024-00828-8

Abstract:Hepatocellular carcinoma (HCC) frequently recurs from minimal residual disease (MRD), which persists after therapy. Here, we identified mechanisms of persistence of residual tumor cells using post-chemoembolization human HCC (n = 108 patients, 1.07 million cells) and a transgenic mouse model of MRD. Through single-cell high-plex cytometric imaging, we identified a spatial neighborhood within which PD-L1 + M2-like macrophages interact with stem-like tumor cells, correlating with CD8+ T cell exhaustion and poor survival. Further, through spatial transcriptomics of residual HCC, we showed that macrophage-derived TGFβ1 mediates the persistence of stem-like tumor cells. Last, we demonstrate that combined blockade of Pdl1 and Tgfβ excluded immunosuppressive macrophages, recruited activated CD8+ T cells and eliminated residual stem-like tumor cells in two mouse models: a transgenic model of MRD and a syngeneic orthotopic model of doxorubicin-resistant HCC. Thus, our spatial analyses reveal that PD-L1+ macrophages sustain MRD by activating the TGFβ pathway in stem-like cancer cells and targeting this interaction may prevent HCC recurrence from MRD.